Home/ Supplements/ Lysine/ L-Lysine

L-Lysine

product on market Tablet or Pill DaVinci Laboratories Of Vermont Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
100
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Stearic Acid Vegetable Stearate Croscarmellose Sodium Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 tablet, 1 to 3 times daily between meals, or as directed by your health care practitioner.

Warnings & Precautions

Warning: If pregnant or nursing, consult your health care practitioner before taking this product.

Keep out of reach of children.

Formulation Notes

This product is vegetarian and free of citrus, corn, gluten, rice and yeast.

This product is vegetarian and free of citrus, corn, gluten, rice and yeast.

VEGETARIAN

Additional Information

TRUTH We pledge total truth in labeling. Our family of products contain only the purest and most potent ingredients. Guaranteed.

Color of this product may vary due to color variations of natural ingredients.

Store in a cool, dry place.

0200281.100 0310A

9768500 1012

Metadata

Product Details

UPC / SKU0 26664 22811 6
DSLD Entry Date2013-06-25
Product TypeAmino acid/Protein
FormTablet or Pill
DSLD ID22874
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.